Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 262

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

A map of human cancer signaling

Open access
Cui, Qinghua, Ma, Yun, Jaramillo, Maria, Bari, Hamza, Awan, Arif, Yang, Song, Zhang, Simo, Liu, Lixue, Lu, Meng, O'Connor‐McCourt, Maureen, Purisima, Enrico O, Wang, Edwin·2007·Molecular Systems Biology

Abstract

We conducted a comprehensive analysis of a manually curated human signaling network containing 1634 nodes and 5089 signaling regulatory relations by integrating cancer‐associated genetically and epigenetically altered genes. We find that cancer mutated genes are enriched in positive signaling regulatory loops, whereas the cancer‐associated methylated genes are enriched in negative signaling regulatory loops. We further characterized an overall picture of the cancer‐signaling architectural and functional organization. From the network, we extracted an oncogene‐signaling map, which contains 326 nodes, 892 links and the interconnections of mutated and methylated genes. The map can be decomposed into 12 topological regions or oncogene‐signaling blocks, including a few ‘oncogene‐signaling‐dependent blocks’ in which frequently used oncogene‐signaling events are enriched. One such block, in which the genes are highly mutated and methylated, appears in most tumors and thus plays a central role in cancer signaling. Functional collaborations between two oncogene‐signaling‐dependent blocks occur in most tumors, although breast and lung tumors exhibit more complex collaborative patterns between multiple blocks than other cancer types. Benchmarking two data sets derived from systematic screening of mutations in tumors further reinforced our findings that, although the mutations are tremendously diverse and complex at the gene level, clear patterns of oncogene‐signaling collaborations emerge recurrently at the network level. Finally, the mutated genes in the network could be used to discover novel cancer‐associated genes and biomarkers. Cancer is largely a genetic disease that is caused by acquiring genomic alterations in cells. It is proposed that a malignant tumor arises from a single cell, which undergoes a series of evolutionary processes of genetic or epigenetic changes and selections so that a cell within the population can acquire additional selective advantages, resulting in progressive clonal expansion (Nowell, 1976). Enormous efforts have been made over the past few decades to identify gene mutations that are causally implicated in human cancer. Recently, a whole‐genome or large‐scale efforts toward the identification of genetic and epigenetic changes in tumor samples have been conducted (Stephens et al, 2005; Sjoblom et al, 2006; Greenman et al, 2007; Ohm et al, 2007; Schlesinger et al, 2007; Thomas et al, 2007; Widschwendter et al, 2007). These studies showed that a substantial fraction of the cancer‐associated mutated and methylated genes is involved in cell signaling. Although a wide variety of genetic and epigenetic alterations contribute to the signaling of tumorigenesis, it has been challenging to gain a global view of where and how they affect the signaling alterations to generate tumors on the entire signaling network. To address this question, we performed an integrative analysis of a human signaling network incorporating the cancer mutated and methylated genes. We uncovered an overall picture of the network architecture to determine the sites at which oncogenic stimuli occur and the oncogenic regulatory mechanisms underlying the mutated and methylated genes. Genetic mutations preferentially occur in the proteins (signaling hubs) that receive and send more signals but not in the proteins (neutral hubs) that simply have more physical interactions with others. However, methylated genes have no such preference. Furthermore, we showed that genetic mutations are enriched in positive regulatory loops, whereas methylated genes are enriched in negative regulatory loops. These results suggest that genetic and methylated alterations have different regulatory mechanisms in tumorigenesis. Signaling information propagates through a series of built‐in regulatory motifs to contribute to cellular phenotypic functions (Ma'ayan et al, 2005). The transition from a normal cellular state into an oncogenic state is often driven by prolonged activation of downstream proteins, which are regulated by upstream proteins or regulatory motifs. In cancer cells, constitutive activation of the oncogene signaling is necessary. The enrichment of genetic mutations in positive regulatory loops suggests that the mutants in the motifs must have gain of function or increase their biochemical activities compared with the wild‐type genes to constitutively activate the downstream proteins. Indeed, a recent survey showed that 14 out of the 15 PI3K mutants in tumors have gain of function (Gymnopoulos et al, 2007). A gain‐of‐function mutant in a positive regulatory loop offers the amplification of weak input stimuli and serves as information storage to extend the duration of activation of the affected downstream proteins. This might allow the downstream signaling cascades to persistently hold and transfer information leading to tumor phenotypes. One the other hand, methylation is a known mechanism of inducing loss of function of genes (Ohm et al

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/msb4100200

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

Metadata

Authors
Cui, Q., Ma, Y., Jaramillo, M., Bari, H., Awan, A., Yang, S., Zhang, S., Liu, L., Lu, M., O'Connor‐McCourt, M., Purisima, E. O., & Wang, E.
Venue
Molecular Systems Biology
Published
2007-01
Volume
3
Issue
1
Pages
152-152
ISSN
1744-4292 (ISSN-L)
OpenAlex
W2116298046
Cited by
262
References
36
FWCI
5.99
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.